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Background: A mechanism for myocardial dysfunction after ischemia and reperfu-
sion is Na/H exchanger activation. Although past in vivo models of limited
ischemia and reperfusion intervals demonstrate that Na/H exchanger inhibition
confers myocardial protection when administered at the onset of ischemia, the effect
of Na/H exchanger inhibition on myocardial function after prolonged ischemia
and reperfusion remains unknown. This investigation tested the hypothesis that
Na/H exchanger inhibition instituted at reperfusion and after prolonged coronary
occlusion in pigs would influence myocardial contractility independent of myocar-
dial viability.
Methods: A coronary snare and sonomicrometry crystals were placed in pigs (n 
21, 32 kg). Coronary occlusion was instituted for 120 minutes followed by reper-
fusion for 180 minutes. At 105 minutes of ischemia, pigs were randomized to
ischemia and reperfusion only (saline solution, n  11) or Na/H exchanger
inhibition (HOE-642, 3 mg/kg intravenously, n  10). Myocardial injury was
determined by tissue staining and measurement of plasma myocyte–specific en-
zymes. Myocardial contractility was determined by calculation of the regional
end-systolic pressure-dimension relation (millimeters of mercury per centimeter)
and by assessment of interregional shortening.
Results: Infarct size was not different between groups (39%  6%, P  .26).
Moreover, at 180 minutes of reperfusion, plasma troponin-I and creatine kinase MB
values had increased to identical levels in the ischemia and reperfusion–only and
Na/H exchanger inhibition groups (300  35 and 50  6 ng/mL, respectively).
At 90 minutes of ischemia, regional end-systolic pressure-dimension relation de-
creased from baseline (5.7  0.5 versus 2.7  0.3, P  .05) in the area at risk. By
30 minutes of reperfusion, regional end-systolic pressure-dimension relation de-
creased further in the ischemia and reperfusion–only group (1.6 0.2, P .05), but
improved with Na/H exchanger inhibition (4.4  0.7, P  .05).
Conclusions: Na/H exchanger inhibition instituted at reperfusion improved con-
tractility independent of myocardial viability as assessed by absolute infarct size and
myocyte-specific enzyme release. Thus, modulation of Na/H exchanger ac-
tivity in the setting of prolonged ischemia and reperfusion may hold therapeutic
potential.
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Efforts to attenuate myocardial injury and im-prove survival after the onset of myocardialischemia hinge on prompt restoration of cor-onary blood flow using both pharmacologicand mechanical interventions.1,2 However,reestablishment of myocardial perfusion is
not without adverse consequences.3,4 Specifically, reperfu-
sion of ischemic myocardium may ignite a cascade of
cellular events known to result in myocyte injury through a
process distinct from that encountered by ischemia alone.5,6
This process, ischemia-reperfusion (IR) injury, is likely
attributable to perturbations in calcium homeostasis within
myocytes and can result in contractile dysfunction.4,7 Past in
vitro studies demonstrate that a contributory mechanism for
IR dysfunction is increased activation of the Na/H ex-
changer (NHE) causing an intracellular Na shift and sub-
sequent calcium accumulation.8-10 Calcium overload is
known to prompt cell death through several mechanisms,
which include protease activation and direct mitochondrial
injury.4,11 Moreover, the role of the activated NHE as a
causative entity in the pathogenesis of IR injury has been
supported by numerous investigations in which intact mod-
els of myocardial IR injury were used.12-18 These preclinical
investigations demonstrated that NHE inhibition (NHEI)
conferred myocardial protection, as evidenced by reduction
in infarct size after myocardial reperfusion.13-18 However,
while providing proof of concept and the impetus for the
execution of several recent clinical trials,19-22 these preclin-
ical studies are not directly translatable into clinical con-
texts. Specifically, the majority of these experimental stud-
ies used NHEI before the onset of limited ischemic
intervals, a scenario that is infrequently realized in clinical
settings. Therefore, whether and to what degree NHEI in-
fluences myocardial contractility and viability when insti-
tuted at reperfusion after prolonged periods of regional
ischemia remains unexplored. Accordingly, this study used
a porcine model of IR to assess the effects of NHEI on
indices of regional and global myocardial contractility and
viability when instituted at the time of reperfusion and after
a prolonged period of ischemia.
Methods
Study Rationale/Overview
The present study used an acute porcine model in which the effects
of NHEI on steady-state hemodynamics, myocardial injury, and
left ventricular (LV) contractility were assessed after prolonged
myocardial IR. Pigs were used because their coronary anatomy and
response to myocardial ischemia are similar to those of humans.23
The selective NHE inhibitor, cariporide (HOE-642, 4-isopropyl-
3-methyl-sulfonylbenzoyl-guanidine methanesulphonate, 3 mg/
kg), was instituted 15 minutes before reperfusion to simulate the
common clinical scenario of myocardial infarction in which phar-
macologic intervention is administered and coronary reperfusion is
reestablished only after a significant duration of ischemia. This
dose has previously been shown to confer myocardial protection
when administered before the onset of ischemia in experimental
myocardial IR.12,15 All animals were treated and cared for in
accordance with the National Institute of Health Guide for the Care
and Use of Laboratory Animals (National Research Council,
Washington, 1996).
Experimental Design
Short-Term instrumentation. Yorkshire pigs (n  21, 32 kg)
were sedated with diazepam (Valium, 200 mg orally) and anes-
thetized with sufentanyl (2 g/kg intravenously; Baxter Healthcare
Corp, Deerfield, Ill) and etomidate (0.3 mg/kg intravenously; Bed-
ford Laboratories, Bedford, Ohio). The pigs’ lungs were mechan-
ically ventilated and a stable anesthetic plane was achieved with
morphine sulfate (3 mg/kg per hour intravenously, Elkins-Sinn,
Cherry Hill, NJ) and isoflurane (1%, 1.5 L/min O2). Lactated
Ringer’s solution (150 mL/h) was infused throughout the protocol.
An aortic (8F) and venous (7F) line were placed into the carotid
artery and internal jugular vein, respectively, to monitor systemic
pressures and collect plasma. A multilumen thermodilution cath-
eter (7.5F, Baxter Healthcare Corp, Irvine, Calif) was positioned in
the pulmonary artery via the external jugular vein. A median
sternotomy was performed and a vessel loop was placed around
the inferior vena cava. A precalibrated Micro-Tip transducer (7.5
F, Millar Instruments Inc, Houston, Tex) was advanced into the
left ventricle through the apex. Two pairs of piezoelectric crystals
(2 mm, Sonometrics, London, Ontario, Canada) were positioned
against the LV endocardial surface to measure segmental wall
motion (Figure 1). Pressure waveforms and crystal signals were
digitized for subsequent analysis at a sampling frequency of 100
Hz (Sonolab, Sonometrics). A snare was placed around the cir-
cumflex coronary artery just distal to the first obtuse marginal
branch.
Baseline measurements. Steady-state hemodynamic parame-
ters were recorded and LV contractility was determined by using
transient inferior vena caval occlusion and sonomicrometry. Spe-
cifically, the distance between the crystals placed within each
region was recorded at end-diastole and end-systole to compute
segmental shortening. These measurements were used to generate
region-specific end-systolic pressure-segment distance (dimen-
sion, RESPDR) relationships. End-diastolic and end-systolic dis-
tances between the remote and area-at-risk region was determined
as well to calculate interregional shortening.
Myocardial ischemia. Heparin sodium (150 U/kg intrave-
nously, Pharmacia and Upjohn, Kalamazoo, Mich) and lidocaine
HCl (100 mg intravenously) boluses were administered and the
coronary snare was tightened. Regional myocardial ischemia was
confirmed by paradoxical LV posterolateral wall motion, tissue
blanching, and electrocardiographic changes. Episodes of ventric-
ular tachycardia and fibrillation were terminated with boluses of
lidocaine HCl (50 mg, intravenously) and internal defibrillation,
respectively.
Randomization. At 105 minutes of ischemia, the pigs were
randomized to IR only (n  11, 250 mL of normal saline solution
over 15 minutes, intravenously) or NHEI (n  10, HOE-642, 3
mg/kg in 250 mL normal saline solution over 15 minutes, intra-
venously) such that both treatments were completed by 120 min-
utes of ischemia (Figure 1).
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Myocardial reperfusion. After 120 minutes of ischemia, the
coronary snare was removed and the pigs were reperfused for 180
minutes. Preliminary studies confirmed complete reperfusion of
the myocardial area at risk through the use of fluorescent
microspheres.
Infarct sizing and plasma profiles. Following euthanasia, the
hearts from the pigs were extirpated, and midventricular short-axis
sections were obtained to estimate infarct size by triphenyltetra-
zolium chloride (TTC) staining as previously described.24 Infarct
size was computed as a percentage of the myocardial area at
risk.14,15 Plasma troponin-I and creatine kinase MB (CK-MB)
levels were assessed by the AxSYM automated microparticle
enzyme immunoassay analyzer (Abbott Laboratories, Abbott Park,
Ill). Plasma endothelin-1 (ET-1) levels were determined with a
high-sensitivity radioimmunoassay as described previously.25
Data analysis. The sample size used resulted in a computed
power that exceeded 0.80 for indices of LV systolic function.
Temporal changes in hemodynamic parameters, systolic function,
and plasma enzyme values between the IR-only and NHEI groups
were analyzed by a 2-way analysis of variance (ANOVA) fol-
lowed by mean separation using pairwise Bonferroni corrections.
A Pearson-corrected 2 analysis was used to assess differences
between IR groups with respect to a requirement for internal
defibrillation and the total number of defibrillation attempts nec-
essary to restore sinus rhythm. Values are presented as the mean
and standard error of the mean.
Results
During the ischemic interval, 18% and 20% of the pigs
required internal defibrillation in the IR-only and NHEI
groups, respectively, with no difference between groups (2,
P  .92). There was no difference between groups with
respect to the total number of defibrillation attempts re-
quired to reestablish sinus rhythm (2, P  .96). No epi-
sodes of ventricular fibrillation were observed after coro-
Figure 1. Top, A schematic of the heart after instrumentation. Snares were placed around the inferior vena cava
and circumflex coronary artery. Sonomicrometry crystals were positioned along the endocardium of the LV wall
within the anterior (remote) and posterolateral (area at risk, shaded) regions. Bottom, Instrumentation was
followed by a 30-minute equilibration period. After 105 minutes of ischemia, pigs were randomized to IR only or
NHEI (infused for 15 minutes). Reperfusion was initiated 15 minutes later and was continued for 180 minutes.
Systemic hemodynamics and indices of LV systolic function was assessed at 30-minute intervals throughout the
IR protocol.
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nary snare release. One pig in the NHEI group died of
hemodynamic collapse at 150 minutes of reperfusion, re-
sulting in the sample sizes demonstrated in Table 1. Impor-
tantly, all data collected from this animal, including infarct
size, were included and analyzed in the investigation.
Steady-State Hemodynamics
Steady-state hemodynamic measurements are summarized
in Table 1. Because the pigs were treated in identical
fashion for the first 90 minutes of ischemia and analysis of
variance revealed no difference between groups before ran-
domization, the measurements obtained from these initial
time points were pooled. At 180 minutes of reperfusion,
heart rate was increased, and mean arterial pressure and
systemic vascular resistance were decreased in the IR-only
group compared with baseline. Compared with IR-only
values, cardiac output decreased and systemic vascular re-
sistance increased in the NHEI group.
Intraregional Function
By 30 minutes of ischemia, regional shortening and the
RESPDR were decreased from baseline values within the
area at risk in both IR groups (Figure 2). However, by 30
minutes of reperfusion, regional shortening was increased in
the NHEI group compared with IR-only values. Moreover,
the RESPDR was higher in the NHEI group within 15
minutes of NHEI infusion compared with the IR-only
group. Within the remote region, there were no changes in
regional shortening or the RESPDR in either IR group.
Interregional Function
Regional shortening was determined between the remote
and area-at-risk region as an assessment of global LV sys-
tolic function (Figure 3). Interregional shortening was re-
duced at 90 minutes of ischemia in both IR groups. How-
ever, by 120 minutes of ischemia, and throughout the
reperfusion interval, interregional shortening was increased
in the NHEI group compared with IR-only values.
Infarct Sizes and Plasma Profiles
Infarct size, computed as a percentage of the area at risk,
was 39%  6%, and there was no difference between IR
groups (P .26). The plasma levels of the myocyte-specific
enzymes, cardiac troponin-I and CK-MB, and the potent









IR Only 110 8 (27) 113 7 (24)*
NHEI 100 3 (16) 103 4 (21) 105 5 (15) 110 6 (17)
Cardiac output (L/min)
IR only 3.0 0.3 (1.0)* 3.8 0.2 (0.6)†,‡
NHEI 3.7 0.2 (0.8) 2.9 0.1 (0.7)* 3.0 0.3 (0.9)* 3.1 0.3 (0.9)§
Mean aortic pressure (mm Hg)
IR only 69 5 (17)*,† 64 2 (8)*,†
NHEI 88 3 (14) 85 3 (18) 73 5 (16)*,† 69 3 (10)*,†
LV peak pressure (mm Hg)
IR only 92 6 (19)*,† 93 2 (6)*,†
NHEI 113 2 (11) 109 3 (17) 97 5 (15)*,† 95 5 (15)*,†
LV end-diastolic pressure (mm Hg)
IR only 10 1 (3) 10 1 (3)
NHEI 10 1 (5) 11 1 (3) 11 1 (3) 11 1 (4)
dP/dt max (mm Hg/s)
IR only 1373 130 (432)* 1631 90 (299)
NHEI 1654 78 (410) 1520 51 (269) 1625 156 (494) 1598 183 (549)
Systemic vascular resistance
(103 dyne · s · cm5)
IR only 2.0 0.2 (0.7)† 1.4 0.1 (0.3)*,†,‡
NHEI 2.0 0.1 (0.5) 2.5 0.2 (0.8)* 2.1 0.2 (0.6) 1.9 0.1 (0.4)†,§
Sample size
IR only 11 11
NHEI 21 21 10 9
Values presented as mean  SEM (standard deviation). NHEI (cariporide, 3 mg/kg) infused over 15 minutes before reperfusion.
*P  .05 versus baseline.
†P  .05 versus 90-minute postischemia.
‡P  .05 versus 30-minute postreperfusion.
§P  .05 versus time-matched IR only values).
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vasoconstrictor peptide ET-1 were serially measured during
the IR protocol and are summarized in Figure 4. Robust
increases in troponin-I and CK-MB levels were observed in
both IR groups immediately after removal of the coronary
snare. ET-1 levels similarly increased in both IR groups
during the ischemic interval. There were no differences in
enzyme plasma levels between the IR groups.
Discussion
Past animal studies suggest that NHE activation contributes
to IR-mediated myocardial injury and dysfunction.12-18
However, these studies did not examine the effects of NHEI
on myocardial injury and function when instituted at reper-
fusion following prolonged ischemia. An evaluation of this
approach may be more clinically relevant as suggested by
recent investigations in patients with prolonged myocardial
IR.19-22 Accordingly, the goal of the present study was to
examine the role of NHEI in a setting of prolonged myo-
cardial IR using an experimental design and animal model
that more closely recapitulate the clinical context. The
unique findings of the present investigation are 2-fold. First,
when instituted at reperfusion, NHEI was associated with
significant and sustained improvements in regional and
global LV systolic function. Second, these improvements
occurred independent of the degree of myocardial injury
sustained during IR as assessed by absolute infarct size and
myocyte-specific enzyme release.
LV Contractility After IR: Effects of NHEI
Previous experimental investigations of myocardial IR dem-
onstrated that NHEI improved viability and indices of LV
systolic function when administered before, or shortly after,
the onset of ischemia.12-18 However, the majority of these
studies used short durations of ischemia and administered
Figure 2. Regional shortening (top) and the regional end-systolic pressure-dimension relation (RESPDR; bottom)
obtained from the area at risk are presented as changes from baseline values. At 90 minutes of ischemia, regional
shortening and the RESPDR were decreased in both IR groups. By 30 minutes of reperfusion, regional shortening
was increased in the NHEI group compared with IR-only values. With respect to the RESPDR, functional
improvements were observed in the NHEI group within 15 minutes of NHEI infusion compared to the IR-only group.
These differences persisted throughout the reperfusion period. #P < .05 versus baseline; P < .05 versus 90
minutes of ischemia; *P < .05 versus IR only.
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NHEI at the onset of coronary occlusion, thus limiting
extrapolation to the clinical context. Moreover, load-inde-
pendent indices of LV contractility, such as pressure-dimen-
sion relationships, were not examined. Therefore, whether
and to what degree NHEI influenced LV contractile perfor-
mance independent of infarct size and myocyte-specific
enzyme release when administered after a prolonged period
of ischemia and at the time of reperfusion remain unknown.
The present investigation built on these past experimental
IR studies and directly addressed this issue in the following
ways. First, an animal model and experimental paradigm
that closely recapitulated the common clinical context of
myocardial IR was used. Second, changes in LV pump
performance after IR were evaluated by the use of indices of
LV contractility such as end-systolic pressure-dimension
relationships, a load independent index of regional systolic
performance. The unique results of the present study dem-
onstrated that NHEI improved indices of regional and
global LV contractility after IR in the absence of significant
effects on infarct size and myocyte-specific enzyme release.
Importantly, although the results of this study mirror those
of recent clinical trials with respect to myocardial inju-
ry,21,22 the observed improvement in LV systolic function
contrasts corresponding results from the same clinical in-
vestigations. This disconnect is likely attributable to differ-
ences in the experimental designs. Specifically, the present
investigation directly interrogated the myocardium during
the acute IR period while past clinical trials used less direct
means to assess LV function weeks after the initial myo-
cardial insult.19,20
Myocardial Injury After IR: Effects of NHEI
In the present study, NHEI failed to significantly attenuate
infarct size when instituted at the time of coronary reperfu-
sion as assessed by postmortem histochemical staining.24
Past experimental studies of IR demonstrated similar fail-
ures of myocardial protection when NHEI was administered
before reperfusion but after significantly shorter periods of
ischemia.13-15 However, the serial evaluation of plasma
levels of myocyte-specific enzymes was not performed in
these past studies. Accordingly, to more closely evaluate the
degree of myocardial injury inflicted by the IR event and the
potential role of NHEI in the manifestation of this process,
the present study used temporal plasma profiling of the
myocyte-specific enzymes troponin-I and CK-MB. Robust
increases in the levels of these enzymes were observed in
both IR groups after snare release. There was no significant
difference in the temporal release of these enzymes between
the IR groups during the reperfusion period. Nevertheless,
despite equivalent degrees of release between groups, indi-
ces of regional and global LV contractility were improved
with NHEI at the time of reperfusion, suggesting that the
observed gains in systolic function occurred independent of
myocardial viability.
Mechanism for Improved LV Function After IR
Ischemia induces perturbations in acid-base homeostasis
within myocytes that may ultimately translate into deterio-
rations in LV contractile performance. The NHE, through a
reversible ion-exchange mechanism, removes intracellular
H that accumulates during periods of ischemia in ex-
change for extracellular Na.8,21,26 Importantly, this com-
pensatory ionic mechanism is coupled to an additional and
Figure 3. Top, A schematic depicting the instrumented left ven-
tricle as observed from a view perpendicular to the LV long-axis.
Sonomicrometry crystals are shown in their approximate endo-
cardial positions in the remote and area-at-risk regions. Regional
shortening was determined between these regions. Because the
distance between the remote and area-at-risk regions approxi-
mated the diameter of the left ventricle, this assessment of
interregional shortening represented an estimate of global LV
systolic function. Bottom, Interregional shortening presented as a
change from baseline values. Shortening was reduced at 90
minutes of ischemia in both IR groups. By 120 minutes of ischemia
and throughout reperfusion, interregional shortening was in-
creased in the NHEI group compared with IR-only values. #P < .05
versus baseline; P < .05 versus 90 minutes of ischemia; *P < .05
versus IR only. LV, Left ventricle (ventricular); RV, right ventricle.
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distinct ion exchanger that responds to increases in intra-
cellular Na by facilitating additional ion exchange with
extracellular Ca2.11,19,27 Thus, the end result of prolonged
myocardial ischemia is detrimental accumulation of intra-
cellular Ca2.10 Increased NHE activity during prolonged
IR may exacerbate LV contractile performance by contrib-
uting to abnormalities in Ca2 sensitivity and homeosta-
sis.27 The present study used NHEI at the time of reperfu-
sion to interrupt this ion-exchange process and abrogate the
effects of excessive Ca2 accumulation on LV contractility.
Despite a prolonged period of ischemia, NHEI was associ-
ated with improved regional and global myocardial contrac-
Figure 4. Plasma levels of troponin-I (top), creatine kinase MB (CK-MB, middle), and endothelin-1 (ET-1, bottom)
were assessed at baseline and during the IR protocol. Marked increases in plasma values of troponin-I and CK-MB
were apparent immediately after myocardial reperfusion, suggesting that the occluded arteries were immediately
patent after snare removal. There were no differences in troponin-I, CK-MB, or ET-1 profiles between the IR groups,
suggesting that equivalent and significant degrees of myocardial ischemia and injury were produced. #P < .05
versus baseline; P < .05 versus 90 minutes of ischemia; P < .05 versus 30 minutes of reperfusion.
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tility when instituted at the time of reperfusion compared
with peak-ischemic and IR-only values. This beneficial ef-
fect was likely achieved through attenuations in myocyte
calcium accumulation during the early reperfusion period
that translated into improved Ca2 sensitivity and ho-




NHEI administered at reperfusion did not appear to ad-
versely influence steady-state hemodynamics. However,
NHEI was associated with increased systemic vascular re-
sistance compared with IR-only values, which may have
contributed to the slight, yet significant, decrease in cardiac
output associated with the NHEI group. The change in
systemic vascular resistance was likely due to the systemic
effects of NHEI on vascular smooth muscle. These systemic
effects not withstanding, significant improvements in re-
gional and global LV contractility were observed with
NHEI administration at reperfusion. Importantly, the bene-
ficial effects conferred by NHEI were not the result of
chronotropic manipulation during the reperfusion interval.
A common physiologic response to myocardial IR is
activation of the neurohormonal system. For example, in-
creased synthesis and/or release of the potent bioactive
peptide endothelin (ET) have been observed in settings of
myocardial IR.28 Moreover, elevated ET levels have been
suggested to exacerbate LV systolic dysfunction in numer-
ous cardiovascular disease states,29 and ET receptor activa-
tion has been shown to result in increased activity of the
NHE.30 The present study demonstrated that ET levels were
elevated at the time of myocardial reperfusion. Although
NHEI had no effect on the upstream elaboration of this
peptide, it was associated with improvements in LV systolic
function in the face of increased ET levels.
Study Limitations and Clinical Implications
The present study used NHEI in a short-term model of
myocardial IR. Therefore, whether and to what degree
NHEI influences LV contractility beyond the acute reper-
fusion period remains to be determined. Moreover, repeti-
tive NHEI dosing during the early reperfusion interval may
have further enhanced the beneficial effects observed in LV
contractile function. The dose of cariporide infused in this
study was similar to that previously used in preclinical
investigations12,13,15 but exceeded that used in recent clin-
ical trials.19,20,22 Finally, direct intracoronary infusion of
cariporide was not assessed. Nevertheless, the results of the
present investigation suggest that an ionic mechanism for
myocardial dysfunction after prolonged IR may be in-
creased NHE activity. Moreover, these results suggest that
the administration of NHEI at the time of myocardial reper-
fusion does not preclude the realization of beneficial effects
on LV systolic function. Rather, NHEI may serve as a
useful adjunct in settings of prolonged IR intervals in which
complex percutaneous coronary interventions and coronary
artery bypass grafting procedures are performed. These
results extend the potential benefits of NHEI institution in
the IR setting beyond that of myocardial salvage alone.
Thus, modulation of the NHE may hold therapeutic poten-
tial in the setting of IR.
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